Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cipla LtdfiledCriticalCipla Ltd
Priority to PA8616401ApriorityCriticalpatent/PA8616401A1/en
Publication of PA8616401A1publicationCriticalpatent/PA8616401A1/en
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Abstract
UNA FORMULACIÓN FARMACÉUTICA QUE CONTIENE UN AGENTE CONTRA LA OBESIDAD, COMO LA SIBUTRAMINA, Y AL MENOS UN ACÍDULO, COMO EL ÁCIDO FUMÁRICO CONJUNTAMENTE CON UN PORTADOR, DILUYENTE O EXCIPIENTE PARA ELLO FARMACÉUTICAMENTE ACEPTABLE.A PHARMACEUTICAL FORMULATION THAT CONTAINS AN AGENT AGAINST OBESITY, LIKE SIBUTRAMINE, AND AT LEAST AN ACCIDLE, LIKE A SMOKE ACID WITH A CARRIER, DILUENTLY OR EXCIPIENT TO THEM PHARMACEUTICALLY ACCEPTABLE.
Solid and stabilized pharmaceutical composition comprising a pharmaceutically active ingredient, titanium oxide and a plasticizer; procedure to stabilize the pharmaceutical composition during a light irradiation.
PHARMACEUTICAL COMPOSITION THAT INCLUDES A CHITOSAN, A COSMETIC OR PHARMACEUTICAL ACTIVE INGREDIENT, AND A VOLATILE SOLVENT; AND ITS USE TO TREAT PSORIASIS, MICOSIS BETWEEN OTHER DISEASES.
COMPOUNDS DERIVED FROM BENZOPIRAZOLES; PROCESS FOR THE PREPARATION OF SUCH COMPOUNDS; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS AND ANOTHER ACTIVE AGENT; AND ITS USE FOR THE TREATMENT OF ASTHMA, INFLAMMATION, AMONG OTHER DISEASES.